**Core Concept**
The question is testing the ability to identify a specific immunohistochemical (IHC) marker for diagnosing a centrally located lung tumor, particularly in a patient with a history of smoking. The correct marker should help differentiate between various tumor types, such as small cell carcinoma (SCC), non-small cell carcinoma (NSCLC), and others.

**Why the Correct Answer is Right**
The centrally located mass with undifferentiated tumor histopathology on bronchoscopic biopsy suggests a diagnosis of small cell carcinoma (SCC), a type of neuroendocrine tumor. The most useful IHC marker for diagnosing SCC is **Synaptophysin**, which is a marker of neuroendocrine differentiation. Synaptophysin is a protein involved in the synthesis and release of neurotransmitters and hormones, and its expression is characteristic of neuroendocrine tumors like SCC.

**Why Each Wrong Option is Incorrect**
**Option A:** **Cytokeratin 7** is a marker that can be positive in NSCLC, but it is not specific for SCC. While it can be helpful in distinguishing between SCC and other tumor types, it is not the most useful marker for diagnosing SCC.

**Option B:** **Vimentin** is a marker that can be expressed in a variety of tumors, including mesothelioma and some types of sarcomas. However, it is not specific for SCC and can lead to false positives.

**Option C:** **TTF-1 (Thyroid Transcription Factor-1)** is a marker that is typically positive in adenocarcinomas of the lung, but not in SCC. While TTF-1 can be helpful in distinguishing between SCC and other tumor types, it is not the most useful marker for diagnosing SCC.

**Clinical Pearl / High-Yield Fact**
When evaluating a centrally located lung tumor with undifferentiated histopathology, it's essential to consider the patient's history of smoking and the possibility of small cell carcinoma. Synaptophysin is a key marker for diagnosing SCC, and its expression can help guide treatment and prognosis.

**Correct Answer:** **D. Synaptophysin**